Distribuzione geografica
Continente #
EU - Europa 2.485
NA - Nord America 2.484
AS - Asia 1.274
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 6.252
Nazione #
US - Stati Uniti d'America 2.466
CN - Cina 1.249
IE - Irlanda 619
UA - Ucraina 547
FI - Finlandia 310
SE - Svezia 304
DE - Germania 270
GB - Regno Unito 164
IT - Italia 124
FR - Francia 69
BE - Belgio 50
NL - Olanda 20
CA - Canada 17
IR - Iran 8
KR - Corea 6
SG - Singapore 5
CO - Colombia 3
EU - Europa 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
IN - India 2
AT - Austria 1
AU - Australia 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
LB - Libano 1
MU - Mauritius 1
MX - Messico 1
TH - Thailandia 1
TR - Turchia 1
VN - Vietnam 1
Totale 6.252
Città #
Chandler 637
Dublin 617
Jacksonville 559
Nanjing 375
Nanchang 181
Princeton 118
Beijing 115
Shenyang 111
Lawrence 109
Ann Arbor 106
Hebei 104
Helsinki 92
Wilmington 92
Jiaxing 88
Boardman 84
Changsha 79
Medford 79
Tianjin 79
Hangzhou 54
Milan 53
Ashburn 51
Brussels 50
Verona 47
Woodbridge 38
Washington 28
Norwalk 15
Toronto 13
Auburn Hills 10
Kunming 9
Zhengzhou 9
Borås 7
Jinan 7
Los Angeles 7
Seattle 7
Fairfield 6
Ningbo 6
Berlin 5
Guangzhou 5
Houston 5
Tappahannock 5
Hanover 4
Shanghai 4
Taizhou 4
Zanjan 4
Falkenstein 3
Lanzhou 3
Redwood City 3
Trieste 3
Andover 2
Blaubeuren 2
Brno 2
Leawood 2
Noicattaro 2
Nürnberg 2
Ostuni 2
Ottawa 2
Romainville 2
Settimo Torinese 2
Zelo Buon Persico 2
Adelaide 1
Aosta 1
Ardabil 1
Brooklyn 1
Cagliari 1
Changchun 1
Cologne 1
Corsico 1
Des Moines 1
Fuzhou 1
Geislingen an der Steige 1
Hanoi 1
Jesi 1
Kemerovo 1
Kiel 1
Konya 1
London 1
Madrid 1
Mannheim 1
Markham 1
Nuremberg 1
Orange 1
Piacenza 1
Redmond 1
Rockville 1
Saint Louis 1
Sassari 1
Schwarzach 1
Scranton 1
Seongnam 1
Singapore 1
St Louis 1
Torino 1
Windsor 1
Winnipeg 1
Totale 4.147
Nome #
Biomedical and functional changes in bronchoalveolar parameters induced by ambroxol treatment of chronic bronchitis 168
Antibiotics and their interaction with the host defense system in vivo. 98
Indoleamine 2,3-dioxygenase in lung allograft tolerance. 89
Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. 87
Chemotherapeutic agents: aspects of their activity on natural mechanisms of defense against infections 87
Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci 77
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 75
The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms 72
Fluoroquinolone derivatives: effects on neutrophil functional tests 71
Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function 70
Chronic bronchitis and immunomodulating therapy 70
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 68
Chemioterapici antitubercolari 68
Changes in monocyte chemotaxis in patients with primary lung neoplasia 67
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 67
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 67
Specific Anti-CMV Reactivity in BAL: A Useful Tool 67
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 66
Effect of glycopeptide antibiotics on human phagocyte activity 65
Broncho-alveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to the onset of bronchiolitis obliterans syndrome 65
Is a large number of sputum specimens necessary for the bacteriological diagnosis of tuberculosis? 65
Uptake of flurithromycin by human polymorphonuclear phagocytes: partial characterization of the entry mechanism. 64
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 64
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 64
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 63
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 63
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 62
Effects of antibiotics on the bactericidal activity of human serum 61
In vitro and ex vivo influence of rifamycins on human phagocytes 61
Pharmacokinetics of cofosfolactamines in subjects with impaired kidney function 61
Antimicrobial activity, pharmacokinetic characteristics and possible uses of fluoroquinolones 61
In vitro and ex vivo effect of antimicrobial agents on the chemotaxis of human neutrophils 61
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis 61
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 61
Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors 61
Non specific immunity in aged healthy subjects and in patients with chronic bronchitis 60
Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. 60
Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin 60
Epidemiology of sustained nosocomial gram-positive infections and therapeutic problems 60
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 60
Diazepam stimulates migration and phagocytosis of human neutrophils: possible contribution of peripheral-type benzodiazepine receptors and intracellular calcium. 59
Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum 59
Defective phagocyte Aspergillus killing associated with recurrent pulmonary Aspergillus infections 58
Influence of cefoperazone on neutrophil functions in volunteers 58
Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms? 58
Complement-dependent bactericidal activity for E. coli K12 in serum of preterm newborn infants 58
Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients 58
Effect of beta-lactam antibiotics on migration and bactericidal activity of human phagocytes 56
Function of the defense system in patients with primary neoplasms of the lung. Preliminary results 56
Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans 56
Antibiotics and inflammatory process: possibile interference 56
In vitro activity of teichomycin against isolates of gram-positive bacteria 55
Serum bacterial reaction by the alternative pathway of complement: potentiation by target multiplicity and modulation by serum factors 55
Mechanism of action of rifamazine, a member of a new class of (dimeric) rifamycins 55
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 55
Evaluation of the host defense system in asthmatic patients 54
Evidence for CD8+ cell increase in long-term PUVA-treated psoriatic patients after PUVA discontinuation 54
Only genuine CD4+CD25+ Tregs may be friends or foes 54
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 54
New developments in antibacterial choice for lower respiratory tract infections in elderly patients 54
Farmacologia moderna con applicazioni cliniche 54
In vitro activity of two new oral cephalosporins, cefixime and cefdinir (CI 983), on human peripheral mononuclear and polymorphonuclear leukocyte functions. 54
Cefotaxime: rate of bacterial killing and interactions with serum and leukocyte activity 54
Genetic bases and mechanisms of bacterial resistance to antibiotic drugs 53
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 53
In vitro and ex vivo effect of cefodizime on phagocytosis 53
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 53
In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime 52
Effect of rifampicin on expression of some episomal genes in E. coli 52
Morphological, ultrastructural, cytochemical and functional analysis of neutrophils deficient in myeloperoxidase 52
Cytokine profile of broncho-alveolar lavage in BOOP and UIP 52
In vitro effect of RU28965 and other macrolide antibiotics on human neutrophil functions 52
Farmaci antielmintici 52
R-factor-mediated suppression of the galactose-sensitive phenotype of Escherichia coli K-12 galE Mutants 52
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 51
A survey of antimicrobial drug resistance in respiratory tract pathogens, isolated in a northern Italian teaching hospital between 1990 and 1999 51
Influence of aging on some specific and nonspecific mechanisms of the host defense system in 146 healthy subjects 50
Immunological and clinical effect of long-term oral treatment with RU 41740 in patients with chronic bronchitis: double-blind trial long-term versus standard dose regimen 50
In vitro and ex vivo effects of cefodizime on human phagocytes 50
Interference of antimicrobial agents in some reactions of host-defense system 50
Effects of antimicrobial agents on some phases of neutrophil chemotaxis 49
Effect of R factors on rifampicin resistance in E. coli 49
Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome 49
Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy 49
Infezioni polmonari ricorrenti da Aspergillus in un caso di deficit selettivo di aspergillogidia dei fagociti 48
Direct action of antibiotics and immunomodulating agents on phagocytosis 47
Infezioni micotiche ricorrenti quale epifenomeno di difetti selettivi di fungicidia dei neutrofili 47
Effects of aminoglycoside antibiotics on neutrophil chemotaxis 47
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop 47
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 47
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 46
Mycobacterial lipoarabinomannan differently affects human polymorphonuclear and mononuclear phagocyte functions differently 46
In vitro effect of RU28965 and other macrolide antibiotics on human neutrophil functions 46
Lymphopenia and decrease in the total number of circulating CD3+ and CD4+ T cells during 'long-term' PUVA treatment for psoriasis 45
In vitro activity of flurithromycin, a novel macrolide antibiotic 45
Rifamicine 45
Peripheral benzodiazepine receptor expression on leukocytes and neutrophil function during anticonvulsant monotherapy 45
Pleiotropic effects of a rifampicin-resistant mutation in E.coli 45
Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli 43
Totale 5.934
Categoria #
all - tutte 16.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.471

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019264 0 0 0 0 8 18 116 1 104 5 2 10
2019/20201.605 440 611 3 102 6 96 21 97 6 176 45 2
2020/2021993 102 79 49 100 0 141 11 122 46 148 142 53
2021/2022449 14 7 13 10 3 12 7 29 29 10 78 237
2022/20231.843 214 100 17 158 200 204 4 122 731 14 48 31
2023/2024353 92 105 43 43 70 0 0 0 0 0 0 0
Totale 6.273